Stock FinancialsFinanzen börsennotierter US-Firmen

REVVITY, INC. RVTY

Laboratory Analytical Instruments · NYSE

Umsatz
$2.75B
-16.9% Jahresübergangsrate
Nettoerlös
$693.09M
+21.8% Jahresübergangsrate
Gesamtvermögen
$12.39B
-8.6% Jahresübergangsrate
EPS
5.55
+23.3% Jahresübergangsrate
Bruttogewinnspanne 25.2% Betriebsergebnis 10.9% Nettomarge 25.2% Einsendungen
Advertisement
Einkommensrechnung
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Revenues $1.39B $664.76M $2.75B $2.03B $1.34B $649.92M $3.31B $2.05B
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
R&D Expense $106.87M $53.60M $216.58M $147.64M $98.49M $50.36M $221.62M $166.98M
SG&A Expense $498.25M $249.72M $1.02B $749.74M $512.22M $260.57M $1.03B $765.83M
Operating Income (Loss) $162.99M $72.23M $300.56M $227.99M $129.84M $44.12M $742.70M $223.40M
Interest Expense — — — — — — — —
Net Income (Loss) $42.24M $42.24M $693.09M $26.01M $26.01M $26.01M $569.18M $569.48M
EPS (Diluted) 0.81 0.35 5.55 1.42 0.66 0.21 4.50 4.90
Bilanz
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Total Assets $12.17B $12.17B $12.39B $12.39B $12.39B $12.39B $13.56B $13.56B
Current Assets $2.24B $2.24B $2.35B $2.35B $2.35B $2.35B $3.00B $3.00B
Cash & Equivalents $991.85M $1.14B $913.16M $1.23B $1.25B $998.08M $454.36M $1.14B
Accounts Receivable $744.67M $744.67M $632.40M $632.40M $632.40M $632.40M $632.81M $632.81M
Inventory $379.50M $379.50M $367.59M $367.59M $367.59M $367.59M $428.06M $428.06M
PP&E (Net) $479.25M $479.25M $482.22M $482.22M $482.22M $482.22M $509.65M $509.65M
Goodwill $6.61B $6.61B $6.53B $6.46B $6.46B $6.46B $6.48B $6.53B
Total Liabilities $4.92B $4.92B $4.73B $4.73B $4.73B $4.73B $5.69B $5.69B
Current Liabilities $1.33B $1.33B $653.10M $653.10M $653.10M $653.10M $1.45B $1.45B
Accounts Payable $185.46M $185.46M $167.46M $167.46M $167.46M $167.46M $204.12M $204.12M
Long-Term Debt — — — — — — — —
Stockholders Equity $7.67B $7.67B $7.38B $7.87B $7.87B $7.87B $7.14B $7.38B
Kassenfluss
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Operating Cash Flow $262.47M $128.16M $91.27M $454.07M $306.18M $147.56M $679.81M $-105.34M
Investing Cash Flow $-15.87M $-6.38M $1.31B $793.49M $103.31M $-18.18M $-132.85M $1.73B
Financing Cash Flow $-466.14M $-163.66M $-947.12M $-935.25M $-61.51M $-35.01M $-661.80M $-927.51M
Stock Repurchases $447.50M $153.59M $388.88M $184.42M $30.31M $10.76M $80.64M $384.01M

Ähnliche Firmen

Mehr erfahren

Daten stammen aus der öffentlichen Datenbank des US-amerikanischen SEC EDGAR. Diese Seite bietet keine Anlageberatung.